ReCode to secure funds for cystic fibrosis gene correction treatments
ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis Foundation to enhance its…
Respiratory
-
-
CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso (osimertinib) for approval in…
-
NHS launches “game-changer” and lifesaving anti-smoking pill
As the UK Government presses ahead with laws to create a smoke-free generation, tens of thousands of smokers will now…
-
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease (LRTD) caused by respiratory…
-
Cambridge University and GSK sign immunology R&D collaboration
GSK has announced a £50m ($54.3m) investment in a new partnership with the University of Cambridge and Cambridge University Hospitals…
-
Boehringer seeks approval for lung fibrosis drug following Phase III win
Boehringer Ingelheim is seeking regulatory approval for nerandomilast after a Phase III trial in idiopathic pulmonary fibrosis (IPF) met its…
-
Regeneron’s Dupixent approved as first adolescent CRSwNP treatment
The US Food and Drug Administration (FDA) has expanded the approval of Dupixent (dupilumab) to include adolescents aged 12 to…
-
GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial
GSK’s asthma drug Nucala (mepolizumab) has met the primary endpoint in a Phase III trial treating patients with chronic obstructive…
-
NMPA approves AstraZeneca’s Fasenra for severe asthma
The China National Medical Products Association (NMPA) has approved AstraZeneca's Fasenra (benralizumab) as a maintenance treatment for individuals aged 12…
-
Dupixent “addresses current gap” in COPD biologics landscape
The approval of Regeneron and Sanofi’s Dupixent (dupilumab) as the first targeted therapy for chronic obstructive pulmonary disease (COPD) has…
